Greenwood Gearhart Inc. grew its stake in CVS Health Corp (NYSE:CVS) by 3.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,912 shares of the pharmacy operator’s stock after purchasing an additional 1,190 shares during the period. Greenwood Gearhart Inc.’s holdings in CVS Health were worth $2,809,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Jackson Grant Investment Advisers Inc. boosted its position in CVS Health by 0.6% during the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 2,881 shares of the pharmacy operator’s stock worth $232,000 after buying an additional 18 shares during the period. Elefante Mark B boosted its position in CVS Health by 0.7% during the 2nd quarter. Elefante Mark B now owns 6,400 shares of the pharmacy operator’s stock worth $515,000 after buying an additional 45 shares during the period. Traynor Capital Management Inc. boosted its position in CVS Health by 1.3% during the 2nd quarter. Traynor Capital Management Inc. now owns 3,676 shares of the pharmacy operator’s stock worth $290,000 after buying an additional 48 shares during the period. Sequoia Financial Advisors LLC boosted its position in CVS Health by 0.8% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 6,406 shares of the pharmacy operator’s stock worth $515,000 after buying an additional 53 shares during the period. Finally, Brookstone Capital Management boosted its position in CVS Health by 1.8% during the 2nd quarter. Brookstone Capital Management now owns 3,153 shares of the pharmacy operator’s stock worth $254,000 after buying an additional 55 shares during the period. Institutional investors own 82.24% of the company’s stock.

Several equities research analysts recently commented on the stock. Raymond James Financial reiterated a “buy” rating on shares of CVS Health in a research report on Monday, December 4th. Deutsche Bank reiterated a “hold” rating on shares of CVS Health in a research report on Tuesday, December 5th. Royal Bank of Canada set a $95.00 target price on shares of CVS Health and gave the stock a “buy” rating in a research report on Monday, December 4th. Robert W. Baird set a $77.00 target price on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, December 4th. Finally, Jefferies Group set a $76.00 target price on shares of CVS Health and gave the stock a “hold” rating in a research report on Monday, December 4th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have issued a buy rating to the company. CVS Health currently has an average rating of “Buy” and an average price target of $86.35.

Shares of CVS Health Corp (NYSE:CVS) traded down $1.19 during midday trading on Wednesday, hitting $71.66. 2,241,887 shares of the stock were exchanged, compared to its average volume of 6,955,034. The firm has a market cap of $74,029.46, a P/E ratio of 12.80, a P/E/G ratio of 1.37 and a beta of 0.89. CVS Health Corp has a 1 year low of $66.45 and a 1 year high of $84.72. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion for the quarter, compared to the consensus estimate of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The company’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.64 EPS. sell-side analysts expect that CVS Health Corp will post 5.9 earnings per share for the current year.

In other news, COO Jonathan C. Roberts sold 85,743 shares of CVS Health stock in a transaction on Monday, September 18th. The shares were sold at an average price of $83.14, for a total value of $7,128,673.02. Following the completion of the sale, the chief operating officer now owns 119,555 shares in the company, valued at approximately $9,939,802.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Thomas M. Moriarty sold 20,547 shares of CVS Health stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the completion of the sale, the executive vice president now owns 43,178 shares of the company’s stock, valued at approximately $3,504,758.26. The disclosure for this sale can be found here. Insiders sold a total of 145,630 shares of company stock valued at $12,017,632 in the last quarter. 0.61% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION NOTICE: “CVS Health Corp (CVS) Shares Bought by Greenwood Gearhart Inc.” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.watchlistnews.com/cvs-health-corp-cvs-shares-bought-by-greenwood-gearhart-inc/1761437.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with Analyst Ratings Network's FREE daily email newsletter.